MetLife (MET)
(Delayed Data from NYSE)
$57.94 USD
+0.89 (1.56%)
Updated Mar 31, 2023 04:00 PM ET
After-Market: $57.93 -0.01 (-0.02%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth B Momentum B VGM
Income Statements
Fiscal Year end for MetLife, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | 12/31/18 | |
---|---|---|---|---|---|
Sales | 69,898 | 71,080 | 67,842 | 69,620 | 67,941 |
Cost Of Goods | 55,005 | 50,368 | 47,765 | 49,136 | 47,920 |
Gross Profit | 14,893 | 20,712 | 20,077 | 20,484 | 20,021 |
Selling & Adminstrative & Depr. & Amort Expenses | 12,034 | 12,586 | 13,150 | 13,689 | 13,714 |
Income After Depreciation & Amortization | 2,859 | 8,126 | 6,927 | 6,795 | 6,307 |
Non-Operating Income | 0 | 0 | 0 | 0 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 2,859 | 8,126 | 6,927 | 6,795 | 6,307 |
Income Taxes | 301 | 1,551 | 1,509 | 886 | 1,179 |
Minority Interest | 19 | 21 | 11 | 10 | 5 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 2,558 | 6,575 | 5,418 | 5,909 | 5,128 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 2,539 | 6,554 | 5,407 | 5,899 | 5,123 |
Depreciation Footnote | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | 12/31/18 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 2,572 | 7,965 | 6,730 | 6,426 | 5,922 |
Depreciation & Amortization (Cash Flow) | -287 | -161 | -197 | -369 | -385 |
Income After Depreciation & Amortization | 2,859 | 8,126 | 6,927 | 6,795 | 6,307 |
Earnings Per Share Data | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | 12/31/18 |
---|---|---|---|---|---|
Average Shares | 808.90 | 869.40 | 913.91 | 944.40 | 1,013.90 |
Diluted EPS Before Non-Recurring Items | 6.85 | 9.15 | 6.16 | 6.11 | 5.39 |
Diluted Net EPS (GAAP) | 2.91 | 7.31 | 5.68 | 6.06 | 4.91 |
Fiscal Year end for MetLife, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/23 | 12/31/22 | 9/30/22 | 6/30/22 | 3/31/22 | |
---|---|---|---|---|---|
Sales | 16,316.00 | 22,270.00 | 15,556.00 | 15,756.00 | 20,089.00 |
Cost Of Goods | 11,381.00 | 19,128.00 | 12,475.00 | 12,021.00 | 15,512.00 |
Gross Profit | 4,935.00 | 3,142.00 | 3,081.00 | 3,735.00 | 4,577.00 |
SG&A, R&D, and Dept/Amort Expenses | 3,208.00 | 2,723.00 | 3,083.00 | 3,020.00 | 3,271.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 1,727.00 | 419.00 | -2.00 | 715.00 | 1,306.00 |
Non-Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | 1,727.00 | 419.00 | -2.00 | 715.00 | 1,306.00 |
Income Taxes | 381.00 | 19.00 | -140.00 | 41.00 | 95.00 |
Minority Interest | 3.00 | 5.00 | 6.00 | 5.00 | 6.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 1,346.00 | 400.00 | 138.00 | 674.00 | 1,211.00 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 1,343.00 | 395.00 | 132.00 | 669.00 | 1,205.00 |
Earnings Per Share Data | 3/31/23 | 12/31/22 | 9/30/22 | 6/30/22 | 3/31/22 |
---|---|---|---|---|---|
Average Shares | 790.20 | 800.70 | 814.50 | 830.50 | 845.20 |
Diluted EPS Before Non-Recurring Items | 1.55 | 1.21 | 2.00 | 2.08 | 2.17 |
Diluted Net EPS (GAAP) | 1.64 | 0.41 | 0.13 | 0.73 | 1.38 |